Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Mölnlycke Health Care unveils new headquarters at GoCo Health Innovation City, marking a new era of collaboration and innovation
Gothenburg, Sweden, 5 March 2025. Mölnlycke Health Care has now established the new headquarters at GoCo Health Innovation City in the Gothenburg region of Sweden. GoCo is a Life Science knowledge hub that brings together companies, scientists, entrepreneurs, health care providers and talent from around the world. The move underscores Mölnlycke's commitment to embracing partnerships and fostering collaboration to drive the health innovations of tomorrow.
“Placing Mölnlycke together with other key players in Life Science is a game-changer. It opens up entirely new possibilities for us to collaborate with experts from various disciplines, and the chance to practice what we preach: embracing partnerships”, says Zlatko Rihter, CEO of Mölnlycke. “Relocating to this new site is a leap forward for Mölnlycke, preparing us for the future with an office designed to meet the new demands of a workplace.”
Investing in a new headquarters as a founding partner at GoCo Health Innovation City provides a unique opportunity to shape and put Gothenburg’s leading MedTech cluster on the map to help revolutionise care. The move reinforces Mölnlycke's strong commitment to Gothenburg, Sweden, and dedication to continue being an attractive employer in the region and beyond.
The state-of-the-art building features significantly improved collaborative spaces, making it easy for everyone to collaborate and socialise with colleagues, customers, and partners. The new headquarters provides three times more capacity for research and development teams compared to before, making room for innovations that can revolutionise care for people and planet.
-Ends-
For more information, please contact:
Latest news
-
EUR bond issue and tender announcement
Mölnlycke intends to issue a new 10-year EUR bond and launches a tender offer for the outstanding EUR 500m bond due February 2025.
-
Mölnlycke Health Care expands investment in Tamer Mölnlycke Care joint venture
Mölnlycke Health Care, a world leading MedTech company, has expanded its commitment to operations in the Middle East by extending its stake from 33.3% to 60% to become majority shareholder in Tamer Mölnlycke Care - a joint venture with Tamer Group, the market leader in healthcare distribution in the Kingdom of Saudi Arabia.
-
Mölnlycke Health Care agrees to acquire leading wound cleansing manufacturer to consolidate its position as global leader in wound care
Mölnlycke signed an agreement to acquire P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound cleansing and moisturizing.
-
Mölnlycke signs a EUR 350 million revolving credit facility
On 28 April 2023, Mölnlycke entered into a new EUR 350 million multicurrency revolving credit facility. The facility has a tenor of five years with two one-year extension options and will be used as a backup for general corporate purposes. The facility is a refinancing of the existing and undrawn revolving credit facility signed in 2017.
-
In 2023 Mölnlycke was awarded a gold medal for Sustainability by EcoVadis
The world’s largest and most trusted provider of business sustainability ratings - EcoVadis, has awarded Mölnlycke a gold medal for our focus on sustainability. They have ranked us in the top 3% of companies worldwide.
-
Mölnlycke integrated Annual Report 2023
Today we are delighted to announce the launch of the Mölnlycke integrated Annual Report 2023. Our dedication to revolutionising care for people and planet contributed to a very successful year with record high annual net sales of EUR 1,924 million and substantial improvements in profitability. We continue to report our sustainability achievements in accordance with the Global Reporting Initiative (GRI) standards.
-
Mölnlycke announces new partnership with burn survivors organisation Phoenix Society
Mölnlycke Health Care is pleased to announce our partnership with Phoenix Society for Burn Survivors.
-
Mölnlycke Health Care secures USD 400 Million in financing from SEK to support global expansion strategy
Stockholm/Gothenburg – 24 June, 2025. Mölnlycke Health Care and The Swedish Export Credit Corporation (SEK) have signed a USD 400 million financing agreement to support the healthcare company’s continued global growth and development.
-
Mölnlycke Health Care’s long-term target to reach net zero emissions validated by Science Based Targets initiative
Gothenburg, Sweden. 13 May, 2025. Mölnlycke’s long-term net zero greenhouse gas (GHG) emission reduction targets have been validated by the Science Based Targets initiative (SBTi), following prior validation of the company’s near-term GHG emission reduction targets.